ACR Meeting Abstracts

ACR Meeting Abstracts

  • Home
  • Meetings Archive
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018 ACR/ARHP Annual Meeting
    • 2017 ACR/ARHP Annual Meeting
    • 2017 ACR/ARHP PRSYM
    • 2016-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • Register
    • View and print all favorites
    • Clear all your favorites
  • Meeting Resource Center

Abstracts tagged "morbidity and mortality"

  • Abstract Number: 290 • 2012 ACR/ARHP Annual Meeting

    Long-Term Outcomes in Neonatal Lupus

    Amit Saxena1, Peter M. Izmirly2, Deborah Friedman3 and Jill P. Buyon4, 1Medicine, New York University School of Medicine, New York, NY, 2Medicine, Division of Rheumatology, NYU School of Medicine, New York, NY, 3Division of Pediatric Cardiology, New York Medical College, Valhalla, NY, 4Department of Medicine, Division of Rheumatology, New York University School of Medicine, New York, NY

    Background/Purpose: Several studies have evaluated mortality and short-term morbidity in neonatal lupus (NL), however there have been no substantive descriptions of the long term cardiac,…
  • Abstract Number: 698 • 2012 ACR/ARHP Annual Meeting

    External Validation of a Two-Year Mortality Risk Prediction Rule in Early Diffuse Systemic Sclerosis Patients

    Robyn T. Domsic1, Svetlana Nihtyanova2, Stephen R. Wisniewski3, Michael J. Fine4, C. Kent Kwoh5, Christopher P. Denton6 and Thomas A. Medsger Jr.7, 1Medicine - Rheumatology, University of Pittsburgh, Pittsburgh, PA, 2Department of Rheumatology, Royal Free Hospital, Medical School, London, England, 3Epidemiology, University of Pittsburgh, Graduate School of Public Health, Pittsburgh, PA, 4General Medicine, University of Pittsburgh and Center for Health Equity Research and Promotion, VA Pittsburgh Healthcare, Pittsburgh, PA, 5School of Medicine, Department of Medicine, Division of Rheumatology and Clinical Immunology, University of Pittsburgh, Pittsburgh, PA, 6Centre for Rheumatology and Connective Tissue Diseases, UCL Medical School, London, United Kingdom, 7Medicine/Rheumatology, Univ of Pittsburgh, Pittsburgh, PA

    Background/Purpose:   The ability to risk stratify patients for short term mortality is important in SSc patient care and clinical trial design; but there is…
  • Abstract Number: 697 • 2012 ACR/ARHP Annual Meeting

    Demographic, Clinical, Serologic and Socioeconomic Measures Each Predict Mortality in Scleroderma

    Allan C. Gelber1, Rebecca L. Manno2, Adrianne Woods1, Ami A. Shah3, Francesco Boin3, Laura K. Hummers3 and Fredrick M. Wigley3, 1Medicine/ Rheumatology, Johns Hopkins University, Baltimore, MD, 2Division of Rheumatology, Johns Hopkins University, Baltimore, MD, 3Division of Rheumatology, Johns Hopkins University School of Medicine, Baltimore, MD

    Multivariate Model 1 Adjusted RR 95%CI           Multivariate Model 2 Adjusted RR 95%CI Male vs Female 1.4 1.1 – 1.9           Male vs Female 1,4…
  • Abstract Number: 696 • 2012 ACR/ARHP Annual Meeting

    Risk Factors for EARLY Mortality in Scleroderma Patients: A Report From the EULAR Scleroderma Trials and Research Group (EUSTAR) Database

    Patricia E. Carreira1, Loreto Carmona2, Beatriz E. Joven3, Christopher P. Denton4, Yannick Allanore5, Ulrich A. Walker6, Marco Matucci-Cerinic7, Ulf Müller-Ladner8 and Eustar9, 1Rheumatology, Hospital Universitario 12 de Octubre, Madrid, Spain, 2Health Sciences School, Universidad Camilo José Cela, Villanueva de la Cañada, Spain, 3Rheumatology, HOSPITAL UNIVERSITARIO 12 DE OCTUBRE, Madrid, Spain, 4Centre for Rheumatology and Connective Tissue Diseases, UCL Medical School, London, United Kingdom, 5Rheumatology, Paris Descartes University, Rheumatology A department, Cochin Hospital, Paris, France, 6Rheumatology, Universitäts-Poliklinik, Felix-Platter Spital, Basel, Switzerland, 7Department of Biomedicine & Division of Rheumatology AOUC, University of Florence, Florence, Italy, 8Abt. f. Rheumatologie u. klinische Immunologie, Osteologie, Physikalische Therapie, Kerckhoff-Klinik GmbH, Bad Nauheim, Germany, 9Florence

    Background/Purpose: to identify risk factors for early mortality in a large group of recently diagnosed systemic sclerosis (SSc) patients Methods: EUSTAR collects prospectively the Minimal…
  • Abstract Number: 728 • 2012 ACR/ARHP Annual Meeting

    Does the Use of Angiotensin Converting Enzyme Inhibitors Prior to Scleroderma Renal Crisis Affect Prognosis ? – Results of the International Scleroderma Renal Crisis Survey

    Marie Hudson1, Murray Baron2, Solene Tatibouet1, Daniel Furst3, Dinesh Khanna4 and International Scleroderma Renal Crisis Study Investigaots5, 1Jewish General Hospital, McGill University, Montreal, QC, Canada, 2Pavillion A, Rm 216, Lady David Institute for Medical Research and Jewish General Hospital, Montreal, QC, Canada, 3David Geffen School of Medicine, Div of Rheumatology, University of California at Los Angeles, Los Angeles, CA, 4Division of Rheumatology, University of Michigan Medical Center, Ann Arbor, MI, 5Montreal

    Background/Purpose: Scleroderma renal crisis (SRC) is an infrequent but life-threatening complication of systemic sclerosis (SSc). The outcome of SRC has improved considerably since the advent…
  • Abstract Number: 724 • 2012 ACR/ARHP Annual Meeting

    Survival, Hospitalization or Need for Combination Therapy At One Year in Patients with Scleroderma-Associated Pulmonary Arterial Hypertension

    Robyn T. Domsic1, Lorinda Chung2, Jessica K. Gordon3, Yona Cloonan4, Virginia D. Steen5 and PHAROS Investigators6, 1Medicine - Rheumatology, University of Pittsburgh, Pittsburgh, PA, 2Rheumatology, Stanford Univ Medical Center, Palo Alto, CA, 3Rheumatology, Hospital for Special Surgery, New York, NY, 4Graduate School of Public Health, University of Pittsburgh, Pittsburgh, PA, 5Department of Rheumatology, Georgetown University Medical Center, Washington, DC, 6Washington, DC, DC

    Background/Purpose: Pulmonary arterial hypertension (PAH) is a leading cause of death in patients with systemic sclerosis (SSc).  Although survival has improved with PAH-specific medications in…
  • Abstract Number: 936 • 2012 ACR/ARHP Annual Meeting

    Autoimmune Diseases: Declining Mortality Between 1999 and 2008 However Continuing to be a Leading Cause of Death in Children-A 10-Year Retrospective Review

    Eric Y. Yen1 and Deborah K. McCurdy2, 1Pediatrics/Rheumatology, UCLA Division of Pediatric Rheumatology, Los Angeles, CA, 2Pediatric Rheumatology, UCLA Division of Pediatric Rheumatology, Los Angeles, CA

    Background/Purpose: Autoimmune diseases are chronic illnesses that cause significant and chronic disability in children and may lead to death. Using mortality data from 1995, Walsh…
  • Abstract Number: 1410 • 2012 ACR/ARHP Annual Meeting

    Relationship Between Individual Organ Damage and Mortality of Systemic Lupus Erythematosus (SLE): A Prospective Cohort Study of 679 Patients

    Chi Chiu Mok, Ling Yin Ho and Ka Lung Yu, Medicine, Tuen Mun Hospital, Hong Kong, Hong Kong

    Background/Purpose: To study the relationship between damage in different organ systems and mortality in patients with SLE. Methods: 679 patients who fulfilled at least 4…
  • Abstract Number: 1407 • 2012 ACR/ARHP Annual Meeting

    The Effect of the Antiphospholipid Syndrome (APS) On Survival in Chinese Patients with SLE: A Prospective Study of 679 Patients

    Chi Chiu Mok, Ling Yin Ho, Ka Lung Yu and Chi Hung To, Medicine, Tuen Mun Hospital, Hong Kong, Hong Kong

    Background/Purpose:  To study the effect of the antiphospholipid syndrome (APS) on survival in Chinese patients with SLE Methods: A cohort of 679 southern Chinese patients…
  • Abstract Number: 1665 • 2012 ACR/ARHP Annual Meeting

    Associations of Race and Ethnicity with Overall Mortality and Cardiovascular Events Among Patients with End-Stage Renal Disease Due to Lupus Nephritis

    Jose A. Gomez-Puerta1, Sushrut Waikar2, Graciela S. Alarcon3, Jun Liu4, Daniel H. Solomon5, Wolfgang C. Winkelmayer6 and Karen H. Costenbader7, 1Section of Clinical Sciences, Division of Rheumatology, Immunology, and Allergy, Brigham and Women's Hospital, Harvard Medical School, Boston, Boston, MA, 2Division of Nephrology, Brigham and Women's Hospital, Harvard Medical School, Boston, Boston, MA, 3Medicine, Department of Medicine, University of Alabama at Birmingham, Birmingham, AL, 4Division of Pharmacoepidemiology and Pharmacoeconomics, Brigham and Women's Hospital, Harvard Medical School, Boston, Boston, MA, 5Division of Rheumatology, Brigham and Women's Hospital, Boston, MA, 6Division of Nephrology, Stanford University School of Medicine, Stanford, CA, 7Division of Rheumatology, Immunology and Allergy, Brigham and Women's Hospital, Harvard Medical School, Boston, MA

    Background/Purpose: Patients with SLE and lupus nephritis (LN) are at elevated risks of cardiovascular disease. Past studies have suggested that African American patients with SLE…
  • Abstract Number: 2044 • 2012 ACR/ARHP Annual Meeting

    Trying to Improve Care: A Review of the Morbidity and Mortality Conference in the Division of Rheumotology

    Michelle Batthish1, Shirley Tse2, Brian M. Feldman3, G. Ross Baker4 and Ronald Laxer5, 1Pediatric Rheumatology, The Hospital for Sick Children, Toronto, ON, Canada, 2Rheumatology, The Hospital for Sick Children and University of Toronto, Toronto, ON, Canada, 3Division of Rheumatology, The Hospital for Sick Children, Toronto, ON, Canada, 4Institute of Health Policy, Management and Evaluation, The University of Toronto, Toronto, ON, Canada, 5Rheumatology, The Hospital for Sick Children, Toronto, ON, Canada

    Background/Purpose: The morbidity and mortality conference (M&MC) is one of academic medicine’s most visible fora for discussion of adverse events and errors; however it is…
  • Abstract Number: 2559 • 2012 ACR/ARHP Annual Meeting

    Mortality in Patients with Psoriatic Arthritis Compared to Patients with Rheumatoid Arthritis, Psoriasis Alone, and the General Population

    Alexis Ogdie1, Kevin Haynes2, Andrea Troxel2, Thorvardur Love3, Hyon K. Choi4 and Joel Gelfand5, 1Rheumatology and Epidemiology, University of Pennsylvania, Philadelphia, PA, 2Clinical Epidemiology and Biostatistics, University of Pennsylvania., Philadelphia, PA, 3Landspitali University Hospital, Reykjavik, Iceland, 4Section of Rheumatology and the Clinical Epidemiology Unit, Boston University School of Medicine, Boston, MA, 5University of Pennsylvania., Philadelphia, PA

    Background/Purpose: Conflicting reports of the mortality risk among patients with psoriatic arthritis (PsA) exist in the literature, however excess mortality has been presumed given the…
  • « Previous Page
  • 1
  • …
  • 4
  • 5
  • 6
Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

ACR Convergence: Where Rheumatology Meets. All Virtual. November 5-9.

ACR Pediatric Rheumatology Symposium 2020

© COPYRIGHT 2021 AMERICAN COLLEGE OF RHEUMATOLOGY

Wiley

  • Home
  • Meetings Archive
  • Advanced Search
  • Meeting Resource Center
  • Online Journal
  • Privacy Policy
  • Permissions Policies
This site uses cookies: Find out more.